Side-chain-anchored Nα-Fmoc-Tyr-OPfp for bidirectional solid-phase synthesis

Organic Letters

Volumn 7, Issue 9, 2005, Pages 1703-1706

  Olsen, Christian A ^a   Jørgensen, Malene R ^a,c   Hansen, Steen H ^a   Witt, Matthias ^b   Jaroszewski, Jerzy W ^a   Franzyk, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BRUKER DALTONIK GMBH   (Germany)

^c CARLSBERG LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BROMINE DERIVATIVE; PHENOL DERIVATIVE; POLYAMINE DERIVATIVE; RESIN; TRITYL DERIVATIVE;

ARTICLE; HYBRID; PEPTIDE SYNTHESIS; SOLID PHASE SYNTHESIS; SPIDER; SUBSTITUTION REACTION; WASP;

COMBINATORIAL CHEMISTRY TECHNIQUES; FLUOROBENZENES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OLIGOPEPTIDES; SPIDER VENOMS; TYROSINE; WASP VENOMS;

EID: 18844377168     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol050305o     Document Type: Article

References (66)

1. Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149-2154.
2. (a) Dolle, R. E. J. Comb. Chem. 2004, 6, 623-679.
3. (b) Furka, A. Drug. Res. Rev. 1995, 36, 1-12.
4. (c) Houghten, R. A. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 5131-5135.
5. (d) Geysen, H. M. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 3998-4002.
6. For a review, see: Ellman, J. A. Acc. Chem. Res. 1996, 29, 132-143.
7. For selected reviews, see: (a) Ortholand, J.-Y.; Ganesan, A. Curr. Opin. Chem. Biol. 2004, 8, 271-280.
8. (b) Breinbauer, R.; Vetter, I. R.; Waldmann, H. Angew. Chem., Int. Ed. 2002, 41, 2878-2890.
9. (c) Nielsen, J. Curr. Opin. Chem. Biol. 2002, 6, 297-305.
10. (d) Hall, D. G.; Manku, S.; Wang, F. J. Comb. Chem. 2001, 3, 125-150.
11. (e) Watson, C. Angew. Chem., Int. Ed. 1999, 38, 1903-1908.
12. For a recent review, see: Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. 2004, 43, 46-58.
13. Vaino, A. R.; Janda, K. D. J. Comb. Chem. 2000, 2, 579-596.
14. For a recent comprehensive review, see: Guillier, F.; Orain, D.; Bradley, M. Chem. Rev. 2000, 100, 2091-2157.
15. (a) Fyles, T. M.; Leznoff, C. C. Can. J. Chem. 1976, 54, 935-942.
16. (b) Fréchet, J. M. J.; Haque, K. E. Tetrahedron Lett. 1975, 16, 3055-3056.
17. (a) Cironi, P.; Manzanares, I.; Albericio, F.; Álvarez, M. Org. Lett. 2003, 5, 2959-2962.
18. (b) Richter, L. S.; Gadek, T. R. Tetrahedron Lett. 1994, 35, 4705-4706.
19. (a) Cabrele, C.; Langer, M.; Beck-Sickinger, G. J. Org. Chem. 1999, 64, 4353-4361.
20. (b) Hamper, B. C.; Dukesherer, D. R.; South, M. S. Tetrahedron Lett. 1996, 37, 3671-3674.
21. Katritzky, A. R.; Cai, X.; Rogovoy, B. V. J. Comb. Chem. 2003, 5, 392-399.
22. Pearson, W. H.; Clark, R. B. Tetrahedron Lett. 1997, 38, 7669-7672.
23. (a) Shankar, B. B.; Yang, D. Y.; Girton, Y. S.; Ganguly, A. K. Tetrahedron Lett. 1998, 39, 2447-2448.
24. (b) Zhu, Z.; Mckittrick, B. Tetrahedron Lett. 1998, 39, 7479-7482.
25. Adams, M. E.; Carney, R. L.; Enderlin, F. E.; Fu, E. T.; Jarema, M. A.; Li, J. P.; Miller, C. A.; Schooley, D. A.; Shapiro, M. J.; Venema, V. J. Biochem. Biophys. Res. Commun. 1987, 148, 678-683.
26. (a) Eldefrawi, A. T.; Eldefrawi, M. E.; Konno, K.; Mansour, N. A.; Nakanishi, K.; Eugene, O.; Usherwood, P. N. R. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4910-4913.
27. (b) Piek, T.; Fokkens, R. H.; Karst, H.; Kruk, C.; Lind, A.; van Marle, J.; Tong, Y. C. In Neurotox 8: Molecular Basis of Drug and Pesticide Action; Lund, G. G., Ed.; Elsevier: Amsterdam; 1988; pp 61-76.
28. (a) Usherwood, P. N. R. Farmaco 2000, 55, 202-205.
29. (b) Mueller, A. L.; Roeloffs, R.; Jackson, H. Alkaloids (Academic Press) 1995, 46, 63-94.
30. For recent reviews, see: (a) Mellor, I. R.; Usherwood, P. N. R. Toxicon 2004, 43, 493-508.
31. (b) Strømgaard, K.; Mellor, I. R. Med. Res. Rev. 2004, 24, 589-620.
32. (c) Strømgaard, K.; Andersen, K.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. Mini Rev. Med. Chem. 2001, 1, 317-338 and references therein.
33. (a) Andersen, T. F.; Strømgaard, K. Tetrahedron Lett. 2004, 45, 7929-7933.
34. (b) Olsen, C. A.; Witt, M.; Jaroszewski, J. W.; Franzyk, H. J. Org. Chem. 2004, 69, 6149-6152.
35. (c) Olsen, C. A.; Witt, M.; Jaroszewski, J. W.; Franzyk, H. Org. Lett. 2003, 5, 4183-4185.
36. (d) Kan, T.; Kobayashi, H.; Fukuyama, T. Synlett 2002, 8, 1338-1340.
37. (e) Jönsson, D. Tetrahedron Lett. 2002, 43, 4793-4796.
38. (f) Manov, N.; Bienz, S. Tetrahedron 2001, 57, 7893-7898.
39. (g) Strømgaard, K.; Andersen, K.; Ruhland, T.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. Synthesis 2001, 877-884.
40. (h) Hone, N. D.; Payne, L. J. Tetrahedron Lett. 2000, 41, 6149-6152.
41. (i) Wang, F.; Manku, S.; Hall, D. G. Org. Lett. 2000, 2, 1581-1583.
42. Strømgaard, K.; Brierley, M. J.; Andersen, K.; Sløk, F. A.; Mellor, I. R.; Usherwood, P. N. R.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. J. Med. Chem. 1999, 42, 5224-5234.
43. (a) Olsen, C. A.; Jørgensen, M. R.; Witt, M.; Mellor, I. R.; Usherwood, P. N. R.; Jaroszewski, J. W.; Franzyk, H. Eur. J. Org. Chem. 2003, 3288-3299.
44. (b) Bruce, M.; Bukownik, R.; Eldefrawi, A. T.; Eldefrawi, M. E.; Goodnow, R.; Kallimopoulos, T.; Konno, K.; Nakanishi, K.; Niwa, M.; Usherwood, P. N. R. Toxicon 1990, 28, 1333-1346.
45. (a) Kromann, H.; Krikstolaityte, S.; Andersen, A. J.; Andersen, K.; Krogsgaard-Larsen, P.; Jaroszewski, J. W.; Egebjerg, J.; Strømgaard, K. J. Med. Chem. 2002, 45, 5745-5754.
46. (b) Strømgaard, K.; Brier, T. J.; Andersen, K.; Mellor, I. R.; Saghyan, A.; Tikhonov, D.; Usherwood, P. N. R.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. J. Med. Chem. 2000, 43, 4526-4533.
47. Jørgensen, M. R.; Olsen, C. A.; Mellor, I. R.; Usherwood, P. N. R.; Witt, M.; Franzyk, H.; Jaroszewski, J. W. J. Med. Chem. 2005, 48, 56-70.
48. Strømgaard, K.; Björnsdottir, I.; Andersen, K.; Brierley, M. J.; Rizoli, S.; Eldursi, N.; Mellor, I. R.; Usherwood, P. N. R.; Hansen, S. H.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. Chirality 2000, 12, 93-102.
49. L-Lysine analogue 3a was previously shown to be twice as potent as PhTX-343. Nakanishi, K.; Goodnow, R.; Konno, K.; Niwa, M.; Bukownik, R.; Kallimopoulos, A.; Usherwood, P. N. R.; Eldefrawi, A. T.; Eldefrawi, M. E. Pure Appl. Chem. 1990, 62, 1223-1230.
50. Carpino, L. A.; Han, G. Y. J. Org. Chem. 1972, 37, 3404-3409.
51. Carpino, L. A.; Tsao, J.-H.; Ringsdorf, H.; Fell, E.; Hettrich, G. J. Chem. Soc., Chem. Commun. 1978, 358-359.
52. Jensen, K. J.; Meldal, M.; Bock, K. J. Chem. Soc., Perkin Trans. 1 1993, 2119-2129.
53. (a) Quibell, M.; Packman, L. C.; Johnson, T. J. Am. Chem. Soc. 1995, 117, 11656-11668.
54. (b) Zikos, C. C.; Ferderigos, N. G. Tetrahedron Lett. 1994, 35, 1767-1768.
55. 3): δ 7.24 (m, 3H), 7.07 (d, J = 7.1 Hz, 2H), 6.98 (d, J = 8.3 Hz, 2H), 6.70 (d, J = 8.3 Hz, 2H), 6.64 (br s, 1H), 6.19 (br s, 1H), 4.55 (m, 1H), 3.15 (m, 2H), 2.89 (m, 2H), 2.48 (t, J = 7.5 Hz, 2H), 2.15 (t, J = 7.4 Hz, 2H), 1.68 (p, J = 7.5 Hz, 2H), 1.56 (sextet, J = 7.4 Hz, 2H), (t, J = 7.4 Hz, 3H).
56. Since the trityl bromide group is rather reactive, it was preferred to prepare small portions of the resin immediately prior to use.
57. See Supporting Information for experimental details.
58. Also, the hybrid toxins containing (S)-2,3-diaminopropanoic acid (A, 14%), (S)-2,4-diaminobutanoic acid (B, 10%), and (S)-ornithine (C, 17%) were prepared. See Supporting Information for characterization data.
59. Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. Tetrahedron Lett. 1993, 34, 3389-3392.
60. Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. J. Org. Chem. 1992, 57, 2497-2502.
61. For an example, see: Jensen, K. J.; Alsina, J.; Songster, M. F.; Vágner, J.; Albericio, F.; Barany, G. J. Am. Chem. Soc. 1998, 120, 5441-5452.
62. Yan, L. Z.; Edwards, P.; Flora, D.; Mayer, J. P. Tetrahedron Lett. 2004, 45, 923-925.
63. Bycroft, B. W.; Chan, W. C.; Hone, N. D.; Millington, S.; Nash, I. A. J. Am. Chem. Soc. 1994, 116, 7415-7416.
64. Hamzé, A.; Martinez, J.; Hernandez, J.-F. J. Org. Chem. 2004, 69, 8394-8402.
65. For examples, see: (a) Backes, B. J.; Harris, J. L.; Leonetti, F.; Craik, C. S.; Ellman, J. A. Nat. Biotechnol. 2000, 18, 187-193.
66. (b) Meldal, M.; Svendsen, I.; Breddam, K.; Auzanneau, F.-I. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3314-3318.